Sure, it's an improvement on Stribild, but it still has cobi and the associated side-effects. There is still a marketing angle here - why have a ritonavir-like booster for an inferior integrase when there is a better integrase that's QD unboosted and all you need to do is get over your fears of Epzicom to have one-pill-once-a-day.
News 
Market Data 
Discover 
